针对携带c.165+5G>C拼接突变的弗里德里希心力衰竭患者进行反感性寡核酸治疗
Pouiré Yameogo1, Selina Aguilar1, Thazha P Prakash2
1Department of Neurology, O'Donnell Brain Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.
Molecular therapy. Nucleic acids
|July 24, 2025
概括
反感性寡核酸 (ASO) 是弗里德里希氏病的潜在治疗方法.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 神经学 神经学
背景情况:
- 弗里德里希缺氧 (FRDA) 是一种渐进的神经退行性疾病.
- 大多数FRDA病例是由于GAA在frataxin基因 (FXN) 中的三重扩张引起的.
- 一个罕见的FRDA患者小组携带影响FXN拼接的点突变.
研究的目的:
- 为了研究FXN c.165+5G>C点突变对拼接的影响.
- 开发和测试用于纠正FXN拼接缺陷的反意义寡核酸 (ASO).
- 探索与ASOs的组合疗法,针对拼接缺陷和GAA扩张.
主要方法:
- 利用患者衍生的纤维细胞来研究FXN拼接.
- 设计和选了一个O-甲乙烯 (MOE) -ASOs的库,针对内基拼接图案.
- 在用MOE-ASOs治疗的细胞中评估了FXN表达和拼接.
- 采用合成转录延长因子1 (Syn-TEF1) 来准GAA扩展的等位基因.
主要成果:
- 证实FXN c.165+5G>C突变导致异常的FXN拼接.
- 选择的MOE-ASOs通过纠正拼接,成功地恢复了患者细胞中的FXN水平.
- 领先的MOE-ASO在迷你FXN基因模型中展示了拼接修复.
- 同时准拼接缺陷和GAA扩张显示了增强有效性的潜力.
结论:
- ASO介导的拼接修复是FRDA患者具有特定点突变的有前途的治疗策略.
- 针对拼接缺陷和GAA扩张的组合疗法可能会改善治疗结果.
- 这种方法为治疗具有有限治疗选择的罕见遗传疾病提供了希望.
相关概念视频
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K


